TrialJournal of the American Society of Nephrology : JASN2018

A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.

Farsad Eskandary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.